MX2012006646A - Inhibidores de diacilglicerol aciltransferas. - Google Patents

Inhibidores de diacilglicerol aciltransferas.

Info

Publication number
MX2012006646A
MX2012006646A MX2012006646A MX2012006646A MX2012006646A MX 2012006646 A MX2012006646 A MX 2012006646A MX 2012006646 A MX2012006646 A MX 2012006646A MX 2012006646 A MX2012006646 A MX 2012006646A MX 2012006646 A MX2012006646 A MX 2012006646A
Authority
MX
Mexico
Prior art keywords
benzazepin
compound
mmol
dihydro
imidazo
Prior art date
Application number
MX2012006646A
Other languages
English (en)
Spanish (es)
Inventor
Macklin Brian Arnold
Erik James Hembre
Jianliang Lu
John Mehnert Schaus
John Robert Rizzo
Thomas James Beauchamp
Emily Jane Canada
Qing Shi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2012006646A publication Critical patent/MX2012006646A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2012006646A 2009-12-10 2010-12-07 Inhibidores de diacilglicerol aciltransferas. MX2012006646A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28531709P 2009-12-10 2009-12-10
PCT/US2010/059158 WO2011071840A1 (en) 2009-12-10 2010-12-07 Inhibitors of diacylglycerol acyltransferase

Publications (1)

Publication Number Publication Date
MX2012006646A true MX2012006646A (es) 2012-06-25

Family

ID=43569741

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006646A MX2012006646A (es) 2009-12-10 2010-12-07 Inhibidores de diacilglicerol aciltransferas.

Country Status (14)

Country Link
US (1) US8299061B2 (enExample)
EP (1) EP2509981B1 (enExample)
JP (1) JP5631411B2 (enExample)
KR (1) KR101395428B1 (enExample)
CN (1) CN102666543B (enExample)
AR (1) AR079170A1 (enExample)
AU (1) AU2010328410B2 (enExample)
BR (1) BR112012013918A2 (enExample)
CA (1) CA2783684C (enExample)
EA (1) EA020128B1 (enExample)
ES (1) ES2509922T3 (enExample)
MX (1) MX2012006646A (enExample)
TW (1) TWI392680B (enExample)
WO (1) WO2011071840A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12013500063A1 (en) 2010-07-16 2022-10-24 Abbvie Bahamas Ltd Phosphine ligands for catalytic reactions
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
CR20180412A (es) 2010-07-16 2018-11-01 Abbvie Ireland Unlimited Co Proceso para preparar compuestos antivirales
WO2015120610A1 (en) * 2014-02-14 2015-08-20 Eli Lilly And Company Gpr142 agonist compound
CN105153195B (zh) * 2015-09-01 2017-09-26 汤文建 一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途
WO2020239074A1 (zh) * 2019-05-31 2020-12-03 南京明德新药研发有限公司 作为rip-1激酶抑制剂的双并环类化合物及其应用
AR122703A1 (es) * 2020-07-01 2022-09-28 Rigel Pharmaceuticals Inc Inhibidores de rip1k

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847248A (en) 1986-12-23 1989-07-11 Merck & Co., Inc. 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists
EP0272866A1 (en) 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 5-membered heterocyclic rings
US4735941A (en) 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
CA2071092A1 (en) 1991-06-14 1992-12-15 Roger M. Freidinger 1,4-benzodiazepines with 5-membered heterocyclic rings
WO1995014694A1 (en) 1993-11-22 1995-06-01 Merck & Co., Inc. Benzodiazepines
EP0730581B1 (en) * 1993-11-22 2001-10-04 Merck & Co. Inc. 3-acylaminobenzazepines
US5439906A (en) 1993-11-22 1995-08-08 Merck & Co., Inc. Antiarrhythmic benzodiazepines
US5834464A (en) 1994-11-18 1998-11-10 Merck & Co., Inc. Imidazolinobenzodiazepines
ZA9711537B (en) 1996-12-23 1998-06-25 Athena Neurosciences Inc Eli L Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting ß-amyloid peptide release and/or its synthesis by use of such compounds.
GB0012671D0 (en) 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
AU2005272627A1 (en) * 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
BRPI0608906A2 (pt) * 2005-05-10 2010-02-17 Hoffmann La Roche composto, processo para a sua manufatura, utilização do mesmo, método para o tratamento de obesidade, diabetes do tipo ii ou sìndrome metabólica e composição farmacêutica que compreende o composto
CA2615463A1 (en) 2005-07-29 2007-02-08 Merck & Co., Inc. Heterocyclic benzodiazepine cgrp receptor antagonists
US7569590B2 (en) 2006-09-19 2009-08-04 Bristol-Myers Squibb Company Use of thianecarboxamides as dgat inhibitors
WO2009126861A2 (en) 2008-04-11 2009-10-15 Bristol-Myers Squibb Company Triazolopyridine compounds useful as dgat1 inhibitors
US8324241B2 (en) 2008-04-11 2012-12-04 Bristol-Myers Squibb Company Triazolo compounds useful as DGAT1 inhibitors
JP2010116364A (ja) 2008-11-14 2010-05-27 Banyu Pharmaceut Co Ltd アゼピノン誘導体
US20110319396A1 (en) 2009-01-23 2011-12-29 Msd K.K. Benzodiazepin-2-on derivatives
EP2398781A1 (en) 2009-02-17 2011-12-28 Msd K.K. 1,4-benzodiazepin-2-on derivatives

Also Published As

Publication number Publication date
AU2010328410A1 (en) 2012-07-26
EA201200868A1 (ru) 2012-12-28
CN102666543B (zh) 2014-12-24
CN102666543A (zh) 2012-09-12
TW201130844A (en) 2011-09-16
AU2010328410B2 (en) 2014-02-06
EP2509981B1 (en) 2014-08-06
US20110144091A1 (en) 2011-06-16
WO2011071840A1 (en) 2011-06-16
CA2783684C (en) 2014-02-25
BR112012013918A2 (pt) 2016-04-26
JP2013513607A (ja) 2013-04-22
TWI392680B (zh) 2013-04-11
AR079170A1 (es) 2011-12-28
ES2509922T3 (es) 2014-10-20
EP2509981A1 (en) 2012-10-17
JP5631411B2 (ja) 2014-11-26
EA020128B1 (ru) 2014-08-29
CA2783684A1 (en) 2011-06-16
US8299061B2 (en) 2012-10-30
KR20120099457A (ko) 2012-09-10
KR101395428B1 (ko) 2014-05-14

Similar Documents

Publication Publication Date Title
CN110511213B (zh) 一种免疫调节剂
JP6313416B2 (ja) Ｉｄｏ阻害剤
MX2012006646A (es) Inhibidores de diacilglicerol aciltransferas.
CN103796989B (zh) 支化的3‑苯基丙酸衍生物和其应用
CN114292272A (zh) 一种核苷类化合物及其用途
US20080234277A1 (en) Novel aza-pyridopyrimidinone derivatives
AU2006239929A1 (en) Dipeptidyl peptidase-IV inhibitors
CA2220407A1 (fr) Diazepino-indoles inhibiteurs de phosphodiesterases 4
EP0785789B1 (fr) Diazepino-indoles inhibiteurs de phosphodiesterases iv
BR112015001546B1 (pt) compostos de ureia e sua utilização como inibidores enzimáticos
JPH04230358A (ja) α−メルカプトアルキルアミンの新規なＮ−置換誘導体、それらの製造法及び中間体、それらの薬剤としての使用並びにそれらを含有する組成物
JP2008231027A (ja) アミノアルコール誘導体及びそれらを有効成分とする免疫抑制剤
CN119661404A (zh) 环烷烃取代胺类衍生物、其制备方法和应用
WO2000014073A1 (fr) Derives de la benzodiazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicaments et compositions